Sonova Holding AGSONVF -0.49%89 EBITDA Margin % is 30.55% as of Mar. 2026, which is 19% above its 10-year median of 25.61. GuruFocus rates SONVF with a GF Score™ of 89/100 and a GF Value™ of $314.08 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Sonova Holding AG ranks better than 85.29% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sonova Holding AG's EBITDA for the
six
months ended in Mar. 2026 was $695 Mil. Sonova Holding AG's Revenue for the
six
months ended in Mar. 2026 was $2,274 Mil. Therefore, Sonova Holding AG's EBITDA margin for the quarter that ended in Mar. 2026 was 30.55%.
Sonova Holding AG (OTCPK:SONVF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Sonova Holding AG EBITDA Margin % Related Terms
Sonova Holding AG EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Sonova Holding AG's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SONVF vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Sonova Holding AG's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sonova Holding AG EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sonova Holding AG's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Sonova Holding AG's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sonova Holding AG (SONVF) has a EBITDA Margin % of 30.55% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sonova Holding AG and its competitors. This is 19% above median its historical median of 25.61. Over the past decade, Sonova Holding AG's EBITDA Margin % has ranged from 23.26 to 32.31. According to the industry distribution chart, Sonova Holding AG ranks #120 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 14.7%.
Is Sonova Holding AG's EBITDA Margin % too high?
Sonova Holding AG's current EBITDA Margin % of 30.55% is 19% above median its 10-year median of 25.61. Over the past 10 years, this metric has ranged from a low of 23.26 to a high of 32.31. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Sonova Holding AG's value of 30.55% is 308.7% above this industry median. Based on the distribution chart, Sonova Holding AG ranks #120 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sonova Holding AG has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sonova Holding AG's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sonova Holding AG ranks #120 out of 816 companies for EBITDA Margin %. This places Sonova Holding AG in the top 15% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.48. Sonova Holding AG's value of 30.55% is 308.7% above this benchmark. Historically, Sonova Holding AG's own EBITDA Margin % has ranged from 23.26 to 32.31 over the past decade. While the company's 10-year median is 25.61 vs. the industry median of 7.48, Sonova Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sonova Holding AG's current EBITDA Margin % of 30.55% is 308.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sonova Holding AG and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sonova Holding AG's current EBITDA Margin % is 30.55%, which is 19% above median its own 10-year median of 25.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonova Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Sonova Holding AG (SONVF) is currently considered Modestly Undervalued. The stock's GF Value™ is $314.08, compared to a current price of $243.88 — trading 22.4% below its estimated fair value. The current EBITDA Margin % is 30.55%, which is 19% above median its 10-year median of 25.61 and 308.7% above the Medical Devices & Instruments industry median of 7.48. Sonova Holding AG's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Sonova Holding AG (SONVF), the current EBITDA Margin % is 30.55% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sonova Holding AG (SONVF) Overvalued in 2026?
Based on GuruFocus' analysis, Sonova Holding AG stock appears to be undervalued.
The current stock price of $243.88 is trading 22.4% below its estimated GF Value™ of $314.08.
GuruFocus considers Sonova Holding AG to be Modestly Undervalued.
Key valuation signals for SONVF:
EBITDA Margin %: 30.55% (19% above median its 10-year median of 25.61)
GF Value™: $314.08 vs. price of $243.88 (22.4% below fair value)
Industry Position: 308.7% above the Medical Devices & Instruments median (#120 of 816)
No single metric tells the full story. See the SONVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sonova is one of the world's largest manufacturers and distributors of hearing aids. The company is based in Switzerland and distributes its products in more than 100 countries through its internal sales team and independent retailers. It also sells cochlear implants and audio technologies.
89GF Score
Get the complete analysis for SONVF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SONVF has been successfully added to your 
